AMTAGVI 72,000,000,000 CELLS in 125 ML Injection

RxCUI: 2675874
RxNorm name: AMTAGVI 72,000,000,000 CELLS in 125 ML Injection
Display name: AMTAGVI 72,000,000,000 CELLS in 125 ML Injection
Full name: AMTAGVI 72,000,000,000 CELLS in 125 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:55

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125773	AMTAGVI	Lifileucel	351(a)	Rx	2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
AMTAGVI	LIFILEUCEL	Iovance Biotherapeutics Inc.	4121bd3f-2d6e-3bdd-e063-6294a90a3088	2025-10-14	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2675874

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
4121bd3f-2d6e-3bdd-e063-6294a90a3088	AMTAGVI 72,000,000,000 CELLS in 125 ML Injection [PSN] · 125 ML lifileucel 576000000 CELLS/ML Injection [Amtagvi] [SBD] · 125 ML Amtagvi 576000000 CELLS/ML Injection [SY] · Amtagvi 72,000,000,000 CELLS per 125 ML Injection [SY]	4	4	These highlights do not include all the information needed to use AMTAGVI safely and effectively. See full prescribing information for AMTAGVI. AMTAGVI (lifileucel) suspension for intravenous infusion Initial U.S. Approval: 2024	20251014
91b0c63a-9a7e-46d0-a562-dc0d7d7867f3	AMTAGVI 72,000,000,000 CELLS in 125 ML Injection [PSN] · 125 ML lifileucel 576000000 CELLS/ML Injection [Amtagvi] [SBD] · 125 ML Amtagvi 576000000 CELLS/ML Injection [SY] · Amtagvi 72,000,000,000 CELLS per 125 ML Injection [SY]	4	3	These highlights do not include all the information needed to use AMTAGVI safely and effectively. See full prescribing information for AMTAGVI. AMTAGVI (lifileucel) suspension for intravenous infusion Initial U.S. Approval: 2024	20250919